Insider trades
Atlas Venture Associates Opportunity II, 10% Owner of Sionna Therapeutics SION, has filed 2 purchases and 29 sales on the open market. The latest trade was on 25/02/10.
Atlas Venture Associates Opportunity II
10% Owner
- Company
- Sionna Therapeutics SION
- First filing
- 24/01/25
- Trades
- 38 trades
- Buys / sales
- 2 / 29
- 12-month net buying
- No record
- Last trade
- 25/02/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/02/10 | 25/02/10 | 60,000 sh | $18.00 | $1,080,000 | +8.0% | |
Korro BioKRRO | Open-market buy | 24/04/22 | 24/04/23 | 17,857 sh | $56.00 | $999,992 | +10.1% |
| Open-market sale10b5-1 plan | 24/03/01 | 24/03/05 | 46,534 sh2 trades | $30.05avg. | $1,398,346.7 | No record | |
| Open-market sale10b5-1 plan | 24/02/26–24/02/28 | 24/02/28 | 807,838 sh18 trades | $24.30avg. | $19,626,902.97 | No record | |
| Open-market sale10b5-1 plan | 24/02/21–24/02/23 | 24/02/23 | 500,789 sh6 trades | $22.64avg. | $11,339,780.44 | No record | |
| Open-market sale | 24/01/23 | 24/01/25 | 150,000 sh3 trades | $67.65avg. | $10,147,500 | No record |